# C4 Therapeutics, Inc.: Form 8-K, filed Mar 11, 2021

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2021-03-11
- Accepted by EDGAR: Mar 11, 2021, 16:10 ET
- Period: 2021-03-10
- Accession: 0001564590-21-012504
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000156459021012504/cccc-8k_20210310.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000156459021012504/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000156459021012504/cccc-8k_20210310.htm

Filed Mar 11, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-012504. Last ingested by Listed: Nov 14, 2026, 19:39 ET. No prices; not investment advice.
